🇩🇪 Germany · EU Public Tender
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Emtricitabin + Rilpivirin + Tenofovir disoproxil fumarat, ATC J05AR08 (OBO) f. d. Z. 01.09.24 - 31.08.26
🏛️ DAK-Gesundheit · 📍 Hamburg
—
Estimated value
05 July 2026
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Deadline | 05 July 2026 |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.